cas 891121-05-4|| where to buy N-[5-(2,5-dimethylphenyl)-1,3,4-oxadiazol-2-yl]-4-(1,2,3,4-tetrahydroisoquinoline-2-sulfonyl)benzamide

Название продукции:N-[5-(2,5-dimethylphenyl)-1,3,4-oxadiazol-2-yl]-4-(1,2,3,4-tetrahydroisoquinoline-2-sulfonyl)benzamide

IUPAC Name:N-[5-(2,5-dimethylphenyl)-1,3,4-oxadiazol-2-yl]-4-(1,2,3,4-tetrahydroisoquinoline-2-sulfonyl)benzamide

: CAS：891121-05-4; Молекулярная формула：C26H24N4O4S; Чистота：95%+

Упаковочная единица	Доступно для заказа	Цена ($)	Количество

Только для использования в НИОКР..

Форма запроса

Химическое название

Номер CAS

Количество*

Необходимые спецификации*
(% пробы, категория материала и т.д.)

Контактное лицо*

Электронная почта*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 891121-05-4 regularly via the above email.

Дополнительные примечания

Verification code*

refresh

: Номер CAS:891121-05-4; Молекулярная формула:C26H24N4O4S; Точка плавления:-; Smiles-код:CC1=CC(C2=NN=C(NC(=O)C3=CC=C(C=C3)S(=O)(=O)N3CCC4=C(C3)C=CC=C4)O2)=C(C)C=C1; Плотность:

: Номер в каталоге:CM991730; Молекулярная масса:488.56; Точка кипения:; Номер Mdl:; Хранение:

: Oxadiazoles; Oxadiazoles are a class of heterocyclic aromatic compounds with the molecular formula C2H2N2O, which have special biological activities and thermodynamic properties. Five-membered heterocyclic moieties composed of three or two heteroatoms are of great interest to researchers because these compounds show significant therapeutic potential. These heterocycles can serve as a building block for the development of novel molecular structures.

: Tetrahydroisoquinolines; Tetrahydroisoquinoline is an organic compound with the chemical formula C9H11N. It is classified as a secondary amine, obtained from isoquinoline by hydrogenation. The tetrahydroisoquinoline moiety forms the backbone of several natural, synthetic and semi-synthetic drugs approved for the treatment of cancer, pain, gout and various neurodegenerative diseases.